SCHEMBL29085907

SCHEMBL29085907

COCCOCC1(CN(C)C(=O)OC(C)(C)C)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28595610 0.88 HTR2C (0.32) —
SCHEMBL28587057 0.86 DPP4 (0.34) —
SCHEMBL28585822 0.85 NFKB1 (0.31) —
SCHEMBL23087060 0.82 MME (0.31) —
SCHEMBL8140265 0.76 USP2 (0.41) —
SCHEMBL31031022 0.76 ASGR1 (0.36) —
SCHEMBL21997499 0.75 USP2 (0.35) —
SCHEMBL23572515 0.74 MEN1 (0.32) —
SCHEMBL23282418 0.72 ASGR1 (0.40) —
SCHEMBL22957198 0.72 PDK2 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12319683-B2 Azabenzimidazole compounds and pharmaceutical NIPPON SHINYAKU CO., LTD. (JP) 2025-06-03 — — US disclosed
EP-3792260-B1 AZABENZIMIDAZOLE COMPOUNDS AND PHARMACEUTICAL NIPPON SHINYAKU CO LTD (JP) 2024-09-11 — — EP disclosed
CN-112368282-B Azabenzimidazole compounds and medicaments 日本新药株式会社 2023-10-13 — — CN disclosed
Send feedback